1. Controlling complement 5a (C5a) in disease setting requires a specifically targeted inhibition. (October 2018) Authors: Guo, Renfeng; Habel, Maria; Ziereisen, Jana; Hermann, Marlen; Xu, Zhongli; Zenker, Othmar; Kirschfink, Michael; Riedemann, Niels Journal: Molecular immunology Issue: Volume 102(2018:Oct.) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Early Intra-Articular Complement Activation in Ankle Fractures. (21st May 2014) Authors: Schmal, Hagen; Salzmann, Gian M.; Niemeyer, Philipp; Langenmair, Elia; Guo, Renfeng; Schneider, Conny; Habel, Maria; Riedemann, Niels Other Names: Leung Frankie Academic Editor. Journal: BioMed research international Issue: Volume 2014(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Elevated Plasma Complement Proteins in Palmoplantar Pustulosis: A Potential Therapeutic Target. Issue 4 (July 2021) Authors: Alavi, Afsaneh; Lowes, Michelle A.; Lu, Justin D.; Xu, Zhongli; Habel, Maria; Guo, Renfeng; Piguet, Vincent Journal: Journal of cutaneous medicine and surgery Issue: Volume 25:Issue 4(2021) Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LB1529. Randomized, Controlled Phase 3 Study of anti-C5a Vilobelimab's Effect on Mortality in Critically Ill COVID-19 Patients: A Therapy for Viral Pneumonia. (15th December 2022) Authors: Mourvillier, Bruno; Vlaar, Alexander; Witzenrath, Martin; Bauer, Michael; Heunks, Leo; Vasquez, Luis Hercilla; Welte, Tobias; van Paassen, Pieter; De Bruin, Sanne; Lim, Endry H T; Tuinman, Pieter R; Saraiva, Jose F; Marx, Gernot; Lobo, Suzana Margareth; Boldo, Rodrigo; Simón Campos, Jesus Abraham... Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗